Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acquired Immunodeficiency Syndrome | 78 | 2012 | 2197 | 2.190 |
Why?
|
HIV Envelope Protein gp120 | 17 | 2012 | 915 | 1.320 |
Why?
|
Methamphetamine | 2 | 2020 | 163 | 1.150 |
Why?
|
HIV-1 | 26 | 2020 | 6850 | 1.140 |
Why?
|
Sarcoma, Kaposi | 26 | 2005 | 376 | 1.130 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 7 | 2014 | 119 | 1.090 |
Why?
|
Megakaryocytes | 18 | 1999 | 566 | 1.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 4 | 2015 | 1655 | 1.070 |
Why?
|
Mitogen-Activated Protein Kinases | 9 | 2007 | 1246 | 0.950 |
Why?
|
Zidovudine | 20 | 1994 | 624 | 0.940 |
Why?
|
Protein-Tyrosine Kinases | 17 | 2001 | 2415 | 0.930 |
Why?
|
Sulfones | 4 | 2012 | 447 | 0.930 |
Why?
|
Receptors, Cell Surface | 6 | 2017 | 2825 | 0.890 |
Why?
|
CD4-Positive T-Lymphocytes | 7 | 2020 | 4355 | 0.850 |
Why?
|
Task Performance and Analysis | 2 | 2016 | 759 | 0.790 |
Why?
|
Efficiency, Organizational | 2 | 2016 | 697 | 0.760 |
Why?
|
Nerve Tissue Proteins | 4 | 2015 | 4409 | 0.730 |
Why?
|
Dendritic Cells | 3 | 2017 | 2730 | 0.680 |
Why?
|
Microfilament Proteins | 2 | 2017 | 1134 | 0.670 |
Why?
|
Lymphoma, Mantle-Cell | 3 | 2012 | 237 | 0.670 |
Why?
|
HIV | 22 | 2012 | 1579 | 0.670 |
Why?
|
Chemokines, CXC | 7 | 2006 | 421 | 0.660 |
Why?
|
Virus Replication | 12 | 2020 | 2431 | 0.650 |
Why?
|
Endothelium, Vascular | 14 | 2010 | 4437 | 0.640 |
Why?
|
Receptors, sigma | 1 | 2019 | 45 | 0.640 |
Why?
|
Focal Adhesion Kinase 2 | 15 | 2012 | 87 | 0.620 |
Why?
|
Herpesvirus 8, Human | 3 | 2007 | 255 | 0.620 |
Why?
|
Salaries and Fringe Benefits | 1 | 2020 | 258 | 0.600 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 14 | 1994 | 886 | 0.590 |
Why?
|
Personal Autonomy | 1 | 2020 | 302 | 0.590 |
Why?
|
HIV Infections | 23 | 2020 | 17159 | 0.570 |
Why?
|
AIDS-Related Complex | 16 | 1992 | 107 | 0.560 |
Why?
|
Professional Competence | 1 | 2020 | 431 | 0.560 |
Why?
|
Receptors, Growth Factor | 5 | 2001 | 326 | 0.540 |
Why?
|
Gene Products, tat | 3 | 2001 | 111 | 0.530 |
Why?
|
Colony-Stimulating Factors | 7 | 1991 | 218 | 0.520 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 2 | 2015 | 160 | 0.520 |
Why?
|
Public Health | 2 | 2024 | 2655 | 0.520 |
Why?
|
Hematopoietic Stem Cells | 12 | 2010 | 3390 | 0.510 |
Why?
|
Hepatocytes | 5 | 2012 | 1228 | 0.510 |
Why?
|
Styrenes | 2 | 2012 | 23 | 0.500 |
Why?
|
Viral Envelope Proteins | 12 | 2005 | 638 | 0.500 |
Why?
|
Cell Adhesion Molecules | 4 | 2017 | 1602 | 0.490 |
Why?
|
Apoptosis | 12 | 2012 | 9497 | 0.490 |
Why?
|
Cell Movement | 12 | 2014 | 5206 | 0.490 |
Why?
|
Phosphorylation | 24 | 2019 | 8314 | 0.490 |
Why?
|
Hepacivirus | 6 | 2012 | 1333 | 0.470 |
Why?
|
Paxillin | 10 | 2012 | 86 | 0.470 |
Why?
|
Receptors, CXCR4 | 6 | 2017 | 728 | 0.460 |
Why?
|
Receptors, Chemokine | 4 | 2007 | 654 | 0.460 |
Why?
|
Interleukin-1beta | 1 | 2020 | 999 | 0.460 |
Why?
|
Cyclin D1 | 3 | 2012 | 453 | 0.460 |
Why?
|
Lectins, C-Type | 2 | 2017 | 591 | 0.450 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2014 | 127 | 0.450 |
Why?
|
Receptor Protein-Tyrosine Kinases | 7 | 2001 | 1614 | 0.440 |
Why?
|
Medicine | 2 | 2012 | 943 | 0.430 |
Why?
|
Enzyme Activation | 13 | 2015 | 3604 | 0.430 |
Why?
|
Research | 4 | 2012 | 1973 | 0.430 |
Why?
|
Hematopoiesis | 13 | 2010 | 2063 | 0.420 |
Why?
|
Cytoskeleton | 4 | 2015 | 1167 | 0.420 |
Why?
|
Endocannabinoids | 2 | 2010 | 111 | 0.420 |
Why?
|
Lymphangiogenesis | 1 | 2014 | 172 | 0.420 |
Why?
|
Religion and Medicine | 2 | 2004 | 160 | 0.410 |
Why?
|
Physician-Patient Relations | 5 | 2010 | 3242 | 0.410 |
Why?
|
Recombinant Proteins | 33 | 2004 | 6543 | 0.400 |
Why?
|
Receptors, CCR5 | 3 | 2017 | 487 | 0.400 |
Why?
|
Endothelium, Lymphatic | 1 | 2012 | 63 | 0.390 |
Why?
|
Didanosine | 4 | 1993 | 151 | 0.390 |
Why?
|
Delivery of Health Care | 3 | 2016 | 5324 | 0.390 |
Why?
|
Receptors, Immunologic | 4 | 2015 | 1434 | 0.390 |
Why?
|
Cocaine | 1 | 2017 | 961 | 0.380 |
Why?
|
Burnout, Professional | 1 | 2020 | 703 | 0.380 |
Why?
|
Deltaretrovirus | 12 | 1986 | 161 | 0.380 |
Why?
|
Central Nervous System Stimulants | 1 | 2020 | 1169 | 0.380 |
Why?
|
Vocabulary | 1 | 2011 | 165 | 0.370 |
Why?
|
Chemotaxis, Leukocyte | 4 | 2006 | 663 | 0.370 |
Why?
|
Interleukin-8 | 3 | 2005 | 698 | 0.370 |
Why?
|
Arachidonic Acids | 2 | 2010 | 294 | 0.370 |
Why?
|
Bisphenol A-Glycidyl Methacrylate | 1 | 2010 | 15 | 0.360 |
Why?
|
Receptor, Cannabinoid, CB2 | 5 | 2010 | 48 | 0.360 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 5 | 1999 | 444 | 0.360 |
Why?
|
Hematopoietic Cell Growth Factors | 5 | 1994 | 98 | 0.360 |
Why?
|
Bone Marrow | 13 | 1997 | 2918 | 0.350 |
Why?
|
Motivation | 1 | 2020 | 1990 | 0.350 |
Why?
|
Signal Transduction | 23 | 2012 | 23363 | 0.340 |
Why?
|
Cytoskeletal Proteins | 10 | 2001 | 1344 | 0.340 |
Why?
|
Tumor Cells, Cultured | 19 | 2012 | 6131 | 0.340 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 2003 | 459 | 0.340 |
Why?
|
Monocytes | 9 | 2001 | 2574 | 0.330 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2012 | 693 | 0.330 |
Why?
|
Glycine | 2 | 2012 | 663 | 0.330 |
Why?
|
Hazardous Substances | 1 | 2010 | 152 | 0.330 |
Why?
|
Ethics, Research | 2 | 2008 | 178 | 0.320 |
Why?
|
History, 20th Century | 7 | 2011 | 2777 | 0.320 |
Why?
|
Humanism | 1 | 2009 | 87 | 0.310 |
Why?
|
Electronic Health Records | 2 | 2016 | 4763 | 0.310 |
Why?
|
Humans | 200 | 2024 | 760261 | 0.310 |
Why?
|
History, 21st Century | 6 | 2011 | 1576 | 0.310 |
Why?
|
Economics, Medical | 1 | 2009 | 112 | 0.310 |
Why?
|
Cell Line | 26 | 2014 | 15626 | 0.310 |
Why?
|
Chemotaxis | 3 | 2007 | 598 | 0.310 |
Why?
|
src-Family Kinases | 4 | 2015 | 534 | 0.300 |
Why?
|
Child Welfare | 2 | 2011 | 517 | 0.300 |
Why?
|
Polychlorinated Biphenyls | 1 | 2010 | 235 | 0.300 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 3 | 2009 | 642 | 0.300 |
Why?
|
Interferon Type I | 8 | 1991 | 559 | 0.300 |
Why?
|
Growth Substances | 7 | 2000 | 768 | 0.300 |
Why?
|
HIV-2 | 5 | 1991 | 156 | 0.300 |
Why?
|
Colic | 1 | 2007 | 44 | 0.300 |
Why?
|
Foundations | 1 | 2008 | 97 | 0.290 |
Why?
|
Fund Raising | 1 | 2008 | 49 | 0.290 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 2 | 2019 | 490 | 0.290 |
Why?
|
Crying | 1 | 2007 | 37 | 0.290 |
Why?
|
Homosexuality | 11 | 1989 | 261 | 0.290 |
Why?
|
Consumer Health Information | 1 | 2010 | 209 | 0.290 |
Why?
|
Retroviridae Infections | 5 | 1990 | 146 | 0.290 |
Why?
|
Physicians | 2 | 2020 | 4590 | 0.290 |
Why?
|
Tyrosine | 7 | 2004 | 1440 | 0.290 |
Why?
|
Cells, Cultured | 24 | 2020 | 18968 | 0.290 |
Why?
|
Phosphoproteins | 11 | 2011 | 2441 | 0.280 |
Why?
|
Interferon-Stimulated Gene Factor 3 | 1 | 2006 | 10 | 0.280 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 5 | 1998 | 489 | 0.280 |
Why?
|
Phosphotyrosine | 4 | 2001 | 456 | 0.280 |
Why?
|
Interleukin-3 | 7 | 1994 | 429 | 0.280 |
Why?
|
Bone Marrow Cells | 12 | 2012 | 2424 | 0.280 |
Why?
|
Drug Industry | 3 | 2009 | 789 | 0.270 |
Why?
|
Tumor Burden | 1 | 2012 | 1897 | 0.270 |
Why?
|
Antineoplastic Agents | 10 | 2012 | 13629 | 0.270 |
Why?
|
Serine | 1 | 2010 | 831 | 0.270 |
Why?
|
Tinnitus | 1 | 2009 | 194 | 0.270 |
Why?
|
Health Care Reform | 2 | 2020 | 1245 | 0.270 |
Why?
|
Infant Care | 1 | 2007 | 180 | 0.260 |
Why?
|
Emotions | 1 | 2017 | 2730 | 0.250 |
Why?
|
Chromosome Mapping | 2 | 2009 | 4625 | 0.250 |
Why?
|
Adaptor Proteins, Signal Transducing | 4 | 2011 | 2895 | 0.250 |
Why?
|
Patient Participation | 2 | 2017 | 1437 | 0.250 |
Why?
|
Gene Products, env | 1 | 2006 | 250 | 0.250 |
Why?
|
T-Lymphocytes | 10 | 2015 | 10183 | 0.250 |
Why?
|
Child Health Services | 1 | 2011 | 644 | 0.250 |
Why?
|
Congenital Abnormalities | 1 | 2010 | 704 | 0.250 |
Why?
|
Stem Cell Factor | 6 | 1998 | 198 | 0.240 |
Why?
|
Antibodies, Viral | 19 | 1988 | 3145 | 0.240 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 3 | 2005 | 478 | 0.240 |
Why?
|
Culture | 1 | 2009 | 622 | 0.240 |
Why?
|
Legislation, Drug | 1 | 2006 | 214 | 0.240 |
Why?
|
Immunoglobulin E | 1 | 2011 | 1493 | 0.240 |
Why?
|
Philosophy, Medical | 1 | 2004 | 79 | 0.240 |
Why?
|
Terminology as Topic | 1 | 2012 | 1534 | 0.240 |
Why?
|
Actin-Related Protein 2-3 Complex | 2 | 2015 | 60 | 0.240 |
Why?
|
Protein Kinase C | 4 | 2004 | 1201 | 0.230 |
Why?
|
Blotting, Western | 8 | 2012 | 5039 | 0.230 |
Why?
|
Middle East | 1 | 2024 | 230 | 0.230 |
Why?
|
Religion | 2 | 2004 | 376 | 0.230 |
Why?
|
Pseudopodia | 2 | 2015 | 168 | 0.220 |
Why?
|
Phosphatidylinositol 3-Kinases | 7 | 2014 | 2866 | 0.220 |
Why?
|
Quality of Health Care | 2 | 2009 | 4361 | 0.220 |
Why?
|
Decision Making | 1 | 2017 | 3924 | 0.220 |
Why?
|
cdc42 GTP-Binding Protein | 2 | 2015 | 187 | 0.220 |
Why?
|
Clergy | 1 | 2004 | 79 | 0.220 |
Why?
|
Cell Adhesion | 8 | 2010 | 3096 | 0.220 |
Why?
|
Protein Binding | 9 | 2015 | 9336 | 0.220 |
Why?
|
Neovascularization, Physiologic | 1 | 2010 | 1335 | 0.220 |
Why?
|
Food Hypersensitivity | 1 | 2011 | 692 | 0.220 |
Why?
|
Protein Biosynthesis | 2 | 2009 | 2104 | 0.210 |
Why?
|
Receptors, Virus | 3 | 1999 | 639 | 0.210 |
Why?
|
Proteins | 6 | 2000 | 6030 | 0.210 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 4 | 2012 | 145 | 0.210 |
Why?
|
Evidence-Based Medicine | 2 | 2012 | 3696 | 0.210 |
Why?
|
Chemokine CXCL12 | 7 | 2006 | 454 | 0.210 |
Why?
|
Erythropoietin | 6 | 1999 | 720 | 0.200 |
Why?
|
Hematologic Diseases | 4 | 1993 | 497 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-akt | 7 | 2014 | 2449 | 0.200 |
Why?
|
Macrophages, Alveolar | 4 | 1999 | 410 | 0.200 |
Why?
|
Decision Support Techniques | 1 | 2012 | 2002 | 0.200 |
Why?
|
Viral Proteins | 5 | 2007 | 1802 | 0.200 |
Why?
|
Transfection | 9 | 2007 | 5782 | 0.200 |
Why?
|
Medical Records Systems, Computerized | 1 | 2008 | 1191 | 0.200 |
Why?
|
Cytokines | 9 | 2011 | 7345 | 0.200 |
Why?
|
Proto-Oncogene Proteins | 8 | 2005 | 4494 | 0.190 |
Why?
|
User-Computer Interface | 1 | 2008 | 1402 | 0.190 |
Why?
|
Interferon-alpha | 5 | 1994 | 919 | 0.190 |
Why?
|
Ethics, Medical | 1 | 2006 | 787 | 0.190 |
Why?
|
Deoxyguanosine | 1 | 2001 | 92 | 0.190 |
Why?
|
Receptor, Cannabinoid, CB1 | 3 | 2010 | 138 | 0.190 |
Why?
|
Granulocyte Colony-Stimulating Factor | 3 | 1992 | 628 | 0.190 |
Why?
|
Truth Disclosure | 1 | 2005 | 432 | 0.190 |
Why?
|
Thrombopoietin | 4 | 1995 | 226 | 0.180 |
Why?
|
Receptors, HIV | 2 | 1999 | 159 | 0.180 |
Why?
|
Gene Expression | 8 | 2017 | 7592 | 0.180 |
Why?
|
Hydrogen Peroxide | 1 | 2004 | 732 | 0.180 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2007 | 2823 | 0.180 |
Why?
|
Eukaryotic Initiation Factor-4E | 2 | 2012 | 112 | 0.180 |
Why?
|
Caspases | 3 | 2005 | 878 | 0.180 |
Why?
|
Enzyme Precursors | 1 | 2000 | 174 | 0.180 |
Why?
|
Mars | 1 | 2000 | 28 | 0.170 |
Why?
|
Chemokines, CC | 1 | 2001 | 283 | 0.170 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 4 | 2009 | 688 | 0.170 |
Why?
|
Interleukin-1 | 5 | 1994 | 1250 | 0.170 |
Why?
|
Cell Survival | 5 | 2007 | 5796 | 0.170 |
Why?
|
Cell Proliferation | 7 | 2014 | 10434 | 0.170 |
Why?
|
Cystic Fibrosis | 1 | 2009 | 1274 | 0.170 |
Why?
|
Drug Approval | 1 | 2006 | 816 | 0.170 |
Why?
|
Transcription Factor AP-1 | 1 | 2001 | 321 | 0.170 |
Why?
|
Weightlessness | 1 | 2000 | 101 | 0.160 |
Why?
|
Cell Division | 10 | 2007 | 4462 | 0.160 |
Why?
|
Astronauts | 1 | 2000 | 92 | 0.160 |
Why?
|
Aerospace Medicine | 1 | 2000 | 95 | 0.160 |
Why?
|
Receptors, Interleukin | 1 | 2000 | 243 | 0.160 |
Why?
|
Integrin alpha5beta1 | 2 | 2012 | 37 | 0.160 |
Why?
|
Cell Cycle | 1 | 2007 | 2937 | 0.160 |
Why?
|
Neutropenia | 5 | 1993 | 884 | 0.160 |
Why?
|
Chemokine CCL2 | 1 | 2001 | 607 | 0.150 |
Why?
|
Cell Line, Tumor | 8 | 2012 | 16905 | 0.150 |
Why?
|
Anemia | 6 | 1999 | 1511 | 0.150 |
Why?
|
United States Food and Drug Administration | 1 | 2006 | 1675 | 0.150 |
Why?
|
Receptors, Dopamine | 1 | 2019 | 292 | 0.150 |
Why?
|
Actins | 3 | 2015 | 2049 | 0.150 |
Why?
|
NF-kappa B | 5 | 2019 | 2486 | 0.150 |
Why?
|
Enzyme Inhibitors | 8 | 2005 | 3726 | 0.150 |
Why?
|
Early Detection of Cancer | 1 | 2012 | 3215 | 0.150 |
Why?
|
Polymerase Chain Reaction | 10 | 2005 | 6067 | 0.150 |
Why?
|
Internet | 1 | 2010 | 3074 | 0.150 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 1998 | 186 | 0.150 |
Why?
|
GTP-Binding Proteins | 2 | 2000 | 951 | 0.150 |
Why?
|
Simian immunodeficiency virus | 2 | 1999 | 805 | 0.150 |
Why?
|
Feedback, Physiological | 1 | 2020 | 476 | 0.140 |
Why?
|
Space Flight | 1 | 2000 | 214 | 0.140 |
Why?
|
Macrophages | 6 | 1998 | 5745 | 0.140 |
Why?
|
Tumor Necrosis Factor-alpha | 8 | 2001 | 4357 | 0.140 |
Why?
|
Immunological Synapses | 1 | 2017 | 59 | 0.140 |
Why?
|
NFATC Transcription Factors | 1 | 2019 | 381 | 0.140 |
Why?
|
Mothers | 1 | 2007 | 2186 | 0.140 |
Why?
|
Focal Adhesions | 1 | 2017 | 115 | 0.140 |
Why?
|
Dose-Response Relationship, Drug | 10 | 2012 | 10829 | 0.140 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 8 | 2012 | 3804 | 0.130 |
Why?
|
Crk-Associated Substrate Protein | 4 | 2000 | 39 | 0.130 |
Why?
|
Calcium | 6 | 2019 | 5726 | 0.130 |
Why?
|
Retinoblastoma-Like Protein p130 | 4 | 2000 | 73 | 0.130 |
Why?
|
Blood Platelets | 3 | 1998 | 2522 | 0.130 |
Why?
|
Myeloid Cells | 1 | 2001 | 821 | 0.130 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 3 | 2001 | 119 | 0.130 |
Why?
|
Carrier Proteins | 4 | 2015 | 4938 | 0.130 |
Why?
|
HIV Long Terminal Repeat | 4 | 1994 | 85 | 0.130 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2006 | 2297 | 0.130 |
Why?
|
Chemokine CCL4 | 3 | 2001 | 127 | 0.130 |
Why?
|
Fibroblast Growth Factor 2 | 2 | 1997 | 590 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 3 | 2005 | 474 | 0.130 |
Why?
|
Macrophage Inflammatory Proteins | 3 | 2001 | 121 | 0.130 |
Why?
|
Cell Surface Extensions | 1 | 2015 | 66 | 0.130 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2012 | 11708 | 0.130 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2017 | 235 | 0.130 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2017 | 150 | 0.130 |
Why?
|
Caspase 3 | 4 | 2007 | 730 | 0.130 |
Why?
|
Virion | 2 | 2015 | 421 | 0.130 |
Why?
|
Retroviridae Proteins | 7 | 1989 | 94 | 0.130 |
Why?
|
Neoplasms | 9 | 2010 | 22066 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2012 | 995 | 0.130 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2015 | 104 | 0.120 |
Why?
|
Drug Evaluation | 8 | 1991 | 642 | 0.120 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2017 | 196 | 0.120 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2012 | 4573 | 0.120 |
Why?
|
Liver Neoplasms | 4 | 2006 | 4317 | 0.120 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 4 | 2001 | 666 | 0.120 |
Why?
|
Protein Kinases | 4 | 2009 | 1612 | 0.120 |
Why?
|
Endothelium | 1 | 1997 | 764 | 0.120 |
Why?
|
Cyclic AMP | 1 | 2019 | 1455 | 0.120 |
Why?
|
HEK293 Cells | 2 | 2015 | 4264 | 0.120 |
Why?
|
DNA Damage | 2 | 2001 | 2442 | 0.120 |
Why?
|
Clinical Trials as Topic | 10 | 2009 | 8058 | 0.120 |
Why?
|
In Situ Nick-End Labeling | 2 | 2007 | 613 | 0.120 |
Why?
|
Flow Cytometry | 6 | 2010 | 5873 | 0.120 |
Why?
|
Blood Transfusion | 5 | 1997 | 1328 | 0.120 |
Why?
|
Cysteine Proteinase Inhibitors | 2 | 2007 | 189 | 0.120 |
Why?
|
Microcirculation | 3 | 2005 | 1279 | 0.110 |
Why?
|
Practice Management, Medical | 1 | 2016 | 191 | 0.110 |
Why?
|
Viral Load | 2 | 2007 | 3323 | 0.110 |
Why?
|
Base Sequence | 11 | 2012 | 12447 | 0.110 |
Why?
|
Endothelial Cells | 3 | 2014 | 3537 | 0.110 |
Why?
|
Antiviral Agents | 6 | 1991 | 3061 | 0.110 |
Why?
|
MicroRNAs | 2 | 2020 | 3784 | 0.110 |
Why?
|
Myelodysplastic Syndromes | 4 | 2012 | 1401 | 0.110 |
Why?
|
HIV Seropositivity | 6 | 1989 | 955 | 0.110 |
Why?
|
Adaptation, Physiological | 1 | 2000 | 1297 | 0.110 |
Why?
|
Protein Transport | 1 | 2019 | 1966 | 0.110 |
Why?
|
Virus Internalization | 1 | 2017 | 494 | 0.110 |
Why?
|
Oligopeptides | 4 | 2005 | 1188 | 0.110 |
Why?
|
Oxidative Stress | 1 | 2004 | 3107 | 0.110 |
Why?
|
Risk Assessment | 2 | 2012 | 24086 | 0.110 |
Why?
|
Hematopoietic Stem Cell Mobilization | 2 | 2010 | 225 | 0.110 |
Why?
|
Vanadates | 2 | 2004 | 82 | 0.100 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2010 | 5248 | 0.100 |
Why?
|
Antigens, CD | 3 | 2000 | 4002 | 0.100 |
Why?
|
Doxorubicin | 4 | 2012 | 2207 | 0.100 |
Why?
|
Binding, Competitive | 4 | 2005 | 1143 | 0.100 |
Why?
|
Connective Tissue Growth Factor | 1 | 2012 | 91 | 0.100 |
Why?
|
Tretinoin | 3 | 2002 | 519 | 0.100 |
Why?
|
Leukopenia | 2 | 1990 | 212 | 0.100 |
Why?
|
Biological Transport | 1 | 2017 | 2087 | 0.100 |
Why?
|
AIDS-Related Opportunistic Infections | 4 | 2000 | 661 | 0.100 |
Why?
|
Genes, src | 1 | 2012 | 51 | 0.100 |
Why?
|
Treatment Outcome | 3 | 2017 | 64947 | 0.100 |
Why?
|
Antigens, Viral | 7 | 1997 | 980 | 0.100 |
Why?
|
Bone Marrow Diseases | 1 | 1994 | 233 | 0.100 |
Why?
|
Liver | 3 | 2005 | 7512 | 0.100 |
Why?
|
Animals | 30 | 2012 | 167940 | 0.100 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2012 | 242 | 0.100 |
Why?
|
DNA, Viral | 5 | 2007 | 2195 | 0.100 |
Why?
|
Genes, nef | 1 | 1991 | 52 | 0.090 |
Why?
|
Quality of Life | 2 | 2012 | 13300 | 0.090 |
Why?
|
Lymphatic Diseases | 3 | 1987 | 319 | 0.090 |
Why?
|
Lymphocytes | 7 | 1991 | 2612 | 0.090 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2003 | 225 | 0.090 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1995 | 1173 | 0.090 |
Why?
|
Communication | 1 | 2005 | 3846 | 0.090 |
Why?
|
Fatigue | 1 | 1998 | 1544 | 0.090 |
Why?
|
Directories as Topic | 1 | 2010 | 8 | 0.090 |
Why?
|
Leukemia, Megakaryoblastic, Acute | 3 | 1998 | 48 | 0.090 |
Why?
|
Water Pollutants | 1 | 2010 | 24 | 0.090 |
Why?
|
Chorioallantoic Membrane | 1 | 2010 | 50 | 0.090 |
Why?
|
Interleukin-6 | 6 | 2002 | 3207 | 0.090 |
Why?
|
Transcription, Genetic | 3 | 2001 | 7593 | 0.090 |
Why?
|
Lung Neoplasms | 4 | 2010 | 13249 | 0.090 |
Why?
|
Lymphoma | 4 | 1999 | 1899 | 0.090 |
Why?
|
src Homology Domains | 2 | 2004 | 362 | 0.090 |
Why?
|
Protein Processing, Post-Translational | 1 | 1998 | 1977 | 0.090 |
Why?
|
Tetradecanoylphorbol Acetate | 6 | 1994 | 819 | 0.090 |
Why?
|
False Positive Reactions | 1 | 2012 | 956 | 0.090 |
Why?
|
Kinetics | 6 | 2003 | 6378 | 0.090 |
Why?
|
United States | 9 | 2020 | 72363 | 0.090 |
Why?
|
Cell Nucleus | 1 | 2019 | 2909 | 0.090 |
Why?
|
Multiple Myeloma | 1 | 2008 | 5131 | 0.090 |
Why?
|
Permeability | 1 | 2012 | 719 | 0.090 |
Why?
|
Microscopy, Confocal | 2 | 2012 | 1972 | 0.080 |
Why?
|
Plastics | 1 | 2010 | 115 | 0.080 |
Why?
|
Lymphatic Vessels | 1 | 2014 | 358 | 0.080 |
Why?
|
Mice | 15 | 2012 | 81216 | 0.080 |
Why?
|
Antineoplastic Agents, Phytogenic | 2 | 2002 | 625 | 0.080 |
Why?
|
Fas Ligand Protein | 3 | 2005 | 215 | 0.080 |
Why?
|
Consumer Product Safety | 1 | 2010 | 123 | 0.080 |
Why?
|
Fibronectins | 2 | 2005 | 721 | 0.080 |
Why?
|
DNA Primers | 5 | 2012 | 2819 | 0.080 |
Why?
|
Lymphocyte Activation | 4 | 1997 | 5498 | 0.080 |
Why?
|
MAP Kinase Signaling System | 3 | 2001 | 1483 | 0.080 |
Why?
|
HIV Antibodies | 11 | 1994 | 1300 | 0.080 |
Why?
|
Government | 1 | 2010 | 160 | 0.080 |
Why?
|
Cannabidiol | 1 | 2011 | 117 | 0.080 |
Why?
|
Histamine | 1 | 2011 | 499 | 0.080 |
Why?
|
Biological Factors | 1 | 1990 | 158 | 0.080 |
Why?
|
Cell Transformation, Viral | 1 | 1990 | 526 | 0.080 |
Why?
|
Patient Access to Records | 1 | 2010 | 119 | 0.080 |
Why?
|
Male | 52 | 2017 | 359413 | 0.080 |
Why?
|
GRB2 Adaptor Protein | 2 | 2000 | 101 | 0.080 |
Why?
|
Antigens, Surface | 2 | 1992 | 1616 | 0.080 |
Why?
|
Thymidine | 4 | 1992 | 299 | 0.080 |
Why?
|
Acrylic Resins | 1 | 2009 | 135 | 0.080 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2012 | 613 | 0.080 |
Why?
|
Opportunistic Infections | 8 | 1991 | 377 | 0.080 |
Why?
|
Viral Core Proteins | 5 | 1990 | 161 | 0.080 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2012 | 675 | 0.080 |
Why?
|
Professional Role | 1 | 2011 | 311 | 0.080 |
Why?
|
raf Kinases | 1 | 2009 | 118 | 0.080 |
Why?
|
History, Ancient | 1 | 2009 | 211 | 0.080 |
Why?
|
Chloramphenicol O-Acetyltransferase | 4 | 1999 | 221 | 0.080 |
Why?
|
Chick Embryo | 1 | 2010 | 981 | 0.080 |
Why?
|
Mitochondria | 3 | 2012 | 3598 | 0.080 |
Why?
|
Host-Pathogen Interactions | 1 | 2017 | 1447 | 0.080 |
Why?
|
Stromal Cells | 2 | 2010 | 1327 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor B | 2 | 1997 | 26 | 0.080 |
Why?
|
Dideoxynucleosides | 1 | 1988 | 132 | 0.080 |
Why?
|
Infant | 2 | 2007 | 36030 | 0.080 |
Why?
|
Lymphokines | 3 | 2000 | 929 | 0.080 |
Why?
|
Interleukin-2 | 2 | 1992 | 1890 | 0.070 |
Why?
|
Peanut Hypersensitivity | 1 | 2011 | 211 | 0.070 |
Why?
|
Cannabinoids | 2 | 2010 | 173 | 0.070 |
Why?
|
Female | 37 | 2017 | 391011 | 0.070 |
Why?
|
Death | 1 | 2012 | 678 | 0.070 |
Why?
|
History, 16th Century | 1 | 2007 | 70 | 0.070 |
Why?
|
Molecular Structure | 2 | 2007 | 1895 | 0.070 |
Why?
|
Receptors, Cannabinoid | 1 | 2007 | 43 | 0.070 |
Why?
|
Economics, Pharmaceutical | 1 | 2008 | 88 | 0.070 |
Why?
|
HIV Core Protein p24 | 4 | 1991 | 245 | 0.070 |
Why?
|
Ethics, Pharmacy | 1 | 2006 | 6 | 0.070 |
Why?
|
Research Design | 3 | 2008 | 6181 | 0.070 |
Why?
|
HIV Antigens | 6 | 1990 | 325 | 0.070 |
Why?
|
MAP Kinase Kinase 4 | 2 | 1997 | 149 | 0.070 |
Why?
|
RNA, Viral | 4 | 2002 | 2837 | 0.070 |
Why?
|
G2 Phase | 1 | 2007 | 133 | 0.070 |
Why?
|
Leukocyte Count | 8 | 1991 | 1600 | 0.070 |
Why?
|
Cost Control | 1 | 2009 | 630 | 0.070 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 2005 | 1746 | 0.070 |
Why?
|
Molecular Sequence Data | 10 | 2001 | 17628 | 0.070 |
Why?
|
Sexual Behavior | 4 | 1989 | 2080 | 0.070 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 616 | 0.070 |
Why?
|
DNA | 6 | 2005 | 7236 | 0.070 |
Why?
|
Endothelial Growth Factors | 2 | 2000 | 674 | 0.070 |
Why?
|
Antigens, CD34 | 2 | 1998 | 652 | 0.070 |
Why?
|
Aflatoxin B1 | 3 | 1997 | 17 | 0.070 |
Why?
|
Commerce | 1 | 2011 | 604 | 0.070 |
Why?
|
Ovarian Neoplasms | 2 | 2000 | 4875 | 0.070 |
Why?
|
Mice, SCID | 2 | 2010 | 2627 | 0.070 |
Why?
|
Drug Therapy | 1 | 2009 | 504 | 0.070 |
Why?
|
Consensus Sequence | 1 | 2006 | 367 | 0.070 |
Why?
|
Muscular Diseases | 1 | 1990 | 551 | 0.060 |
Why?
|
Viral Structural Proteins | 1 | 2005 | 95 | 0.060 |
Why?
|
Public Policy | 1 | 2010 | 560 | 0.060 |
Why?
|
Aging | 1 | 2004 | 8641 | 0.060 |
Why?
|
Adult | 36 | 2012 | 219847 | 0.060 |
Why?
|
Interferons | 1 | 1989 | 705 | 0.060 |
Why?
|
Integrin alpha3beta1 | 1 | 2005 | 53 | 0.060 |
Why?
|
Ligands | 3 | 2005 | 3277 | 0.060 |
Why?
|
Adjuvants, Immunologic | 1 | 1991 | 1041 | 0.060 |
Why?
|
Immune System | 1 | 2011 | 795 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2016 | 7468 | 0.060 |
Why?
|
Plasmids | 3 | 2005 | 2277 | 0.060 |
Why?
|
Vinca Alkaloids | 1 | 1985 | 36 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3451 | 0.060 |
Why?
|
T-Lymphocytes, Helper-Inducer | 3 | 1991 | 975 | 0.060 |
Why?
|
Anecdotes as Topic | 1 | 2004 | 56 | 0.060 |
Why?
|
Trans-Activators | 2 | 2007 | 2861 | 0.060 |
Why?
|
Leukemia, Monocytic, Acute | 2 | 1998 | 58 | 0.060 |
Why?
|
Lipopolysaccharides | 4 | 2010 | 2214 | 0.060 |
Why?
|
Cyclohexanols | 3 | 2010 | 126 | 0.060 |
Why?
|
Erythropoiesis | 1 | 1988 | 682 | 0.060 |
Why?
|
Cattle | 1 | 2010 | 3847 | 0.060 |
Why?
|
Immediate-Early Proteins | 1 | 2007 | 449 | 0.060 |
Why?
|
Epidermal Growth Factor | 1 | 2007 | 695 | 0.060 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2007 | 717 | 0.060 |
Why?
|
Retroviridae Proteins, Oncogenic | 1 | 2004 | 74 | 0.060 |
Why?
|
Dogs | 2 | 1999 | 3843 | 0.060 |
Why?
|
Drug Therapy, Combination | 5 | 1992 | 6499 | 0.060 |
Why?
|
Oncogene Protein v-akt | 1 | 2004 | 129 | 0.060 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2008 | 787 | 0.060 |
Why?
|
Hepatitis C | 2 | 2005 | 1578 | 0.060 |
Why?
|
Focal Adhesion Kinase 1 | 2 | 2001 | 119 | 0.060 |
Why?
|
Gene Expression Regulation | 3 | 2020 | 11902 | 0.060 |
Why?
|
RNA Interference | 1 | 2012 | 2846 | 0.060 |
Why?
|
Costs and Cost Analysis | 2 | 2009 | 1679 | 0.060 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 2 | 2001 | 186 | 0.060 |
Why?
|
Quinuclidines | 1 | 2003 | 24 | 0.060 |
Why?
|
Fibroblasts | 2 | 1992 | 4091 | 0.060 |
Why?
|
Imines | 1 | 2003 | 34 | 0.060 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 4 | 1989 | 900 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2011 | 2058 | 0.050 |
Why?
|
Culture Media, Serum-Free | 2 | 2005 | 148 | 0.050 |
Why?
|
Tissue Plasminogen Activator | 1 | 1989 | 1190 | 0.050 |
Why?
|
Clinical Protocols | 1 | 2009 | 1439 | 0.050 |
Why?
|
Peptide Fragments | 2 | 2014 | 5120 | 0.050 |
Why?
|
RNA-Directed DNA Polymerase | 3 | 1989 | 224 | 0.050 |
Why?
|
Substance Abuse, Intravenous | 1 | 2008 | 529 | 0.050 |
Why?
|
Autophagy | 1 | 2011 | 1336 | 0.050 |
Why?
|
Breast Neoplasms | 5 | 2012 | 21065 | 0.050 |
Why?
|
Gene Products, nef | 1 | 2002 | 100 | 0.050 |
Why?
|
Immunoprecipitation | 1 | 2005 | 877 | 0.050 |
Why?
|
Amino Acid Motifs | 1 | 2005 | 929 | 0.050 |
Why?
|
Benchmarking | 1 | 2009 | 1043 | 0.050 |
Why?
|
Prostate-Specific Antigen | 1 | 2012 | 2528 | 0.050 |
Why?
|
Neoplasm Proteins | 4 | 2000 | 3613 | 0.050 |
Why?
|
Career Choice | 1 | 2009 | 755 | 0.050 |
Why?
|
Language | 1 | 2012 | 1532 | 0.050 |
Why?
|
Genes, p53 | 2 | 1997 | 714 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
Home Care Services | 1 | 2009 | 653 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.050 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2004 | 414 | 0.050 |
Why?
|
Cytopathogenic Effect, Viral | 2 | 1993 | 151 | 0.050 |
Why?
|
HIV Envelope Protein gp160 | 2 | 2000 | 92 | 0.050 |
Why?
|
Workload | 1 | 2008 | 846 | 0.050 |
Why?
|
Proteoglycans | 1 | 2005 | 802 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-crk | 1 | 2001 | 13 | 0.050 |
Why?
|
Open Reading Frames | 1 | 2005 | 814 | 0.050 |
Why?
|
STAT2 Transcription Factor | 1 | 2001 | 27 | 0.050 |
Why?
|
Documentation | 1 | 2008 | 892 | 0.050 |
Why?
|
Tyrphostins | 1 | 2001 | 63 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2003 | 2874 | 0.050 |
Why?
|
STAT4 Transcription Factor | 1 | 2001 | 93 | 0.050 |
Why?
|
Forkhead Transcription Factors | 1 | 2009 | 1613 | 0.050 |
Why?
|
Mammography | 1 | 2012 | 2452 | 0.050 |
Why?
|
Platelet Activation | 2 | 1995 | 661 | 0.050 |
Why?
|
Chemokine CCL3 | 1 | 2001 | 84 | 0.050 |
Why?
|
Colony-Forming Units Assay | 2 | 1994 | 351 | 0.050 |
Why?
|
Administration, Oral | 5 | 2002 | 4044 | 0.050 |
Why?
|
Cloning, Molecular | 3 | 1995 | 4172 | 0.050 |
Why?
|
Fluorescent Antibody Technique | 4 | 2012 | 2473 | 0.050 |
Why?
|
Depression, Chemical | 2 | 1991 | 185 | 0.040 |
Why?
|
Weightlessness Countermeasures | 1 | 2000 | 5 | 0.040 |
Why?
|
Molecular Targeted Therapy | 1 | 2012 | 2805 | 0.040 |
Why?
|
Skin Neoplasms | 3 | 2005 | 5797 | 0.040 |
Why?
|
Disease Outbreaks | 3 | 1987 | 1759 | 0.040 |
Why?
|
Gravity, Altered | 1 | 2000 | 9 | 0.040 |
Why?
|
Receptors, Interleukin-8A | 1 | 2000 | 46 | 0.040 |
Why?
|
United States National Aeronautics and Space Administration | 1 | 2000 | 15 | 0.040 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2000 | 121 | 0.040 |
Why?
|
Receptors, Interleukin-8B | 1 | 2000 | 58 | 0.040 |
Why?
|
Cosmic Radiation | 1 | 2000 | 20 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8621 | 0.040 |
Why?
|
Remission Induction | 3 | 1991 | 2394 | 0.040 |
Why?
|
Membrane Glycoproteins | 3 | 2005 | 3731 | 0.040 |
Why?
|
Antibodies, Monoclonal | 3 | 1993 | 9196 | 0.040 |
Why?
|
Epoetin Alfa | 1 | 1999 | 79 | 0.040 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2000 | 749 | 0.040 |
Why?
|
Drug Administration Schedule | 5 | 2000 | 4900 | 0.040 |
Why?
|
Cell Cycle Proteins | 2 | 2011 | 3448 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2001 | 428 | 0.040 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2001 | 156 | 0.040 |
Why?
|
Hepatitis C, Chronic | 1 | 2008 | 1031 | 0.040 |
Why?
|
Umbilical Veins | 2 | 2006 | 426 | 0.040 |
Why?
|
Culture Media, Conditioned | 1 | 2001 | 522 | 0.040 |
Why?
|
Models, Biological | 1 | 2015 | 9468 | 0.040 |
Why?
|
Transcriptional Activation | 2 | 2005 | 1755 | 0.040 |
Why?
|
Patient-Centered Care | 1 | 2009 | 1416 | 0.040 |
Why?
|
Wound Healing | 1 | 2010 | 2786 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2001 | 482 | 0.040 |
Why?
|
Immunomagnetic Separation | 1 | 1998 | 79 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2001 | 13456 | 0.040 |
Why?
|
Chemokine CXCL10 | 1 | 1999 | 316 | 0.040 |
Why?
|
Pharmaceutical Preparations | 1 | 2006 | 1093 | 0.040 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 1998 | 94 | 0.040 |
Why?
|
Immunosorbent Techniques | 1 | 1998 | 176 | 0.040 |
Why?
|
Interprofessional Relations | 1 | 2004 | 989 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3800 | 0.040 |
Why?
|
Up-Regulation | 2 | 2005 | 4127 | 0.040 |
Why?
|
Janus Kinase 2 | 1 | 2001 | 541 | 0.040 |
Why?
|
Oncostatin M | 1 | 1997 | 42 | 0.040 |
Why?
|
Gene Products, rev | 1 | 1997 | 29 | 0.040 |
Why?
|
Heparin | 1 | 2005 | 1655 | 0.040 |
Why?
|
Skin | 2 | 2007 | 4468 | 0.040 |
Why?
|
Saliva | 3 | 1986 | 816 | 0.040 |
Why?
|
Lymphedema | 1 | 2004 | 525 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-fyn | 1 | 1997 | 110 | 0.040 |
Why?
|
Liver Cirrhosis | 1 | 2008 | 1925 | 0.040 |
Why?
|
B-Lymphocytes | 3 | 1998 | 4739 | 0.040 |
Why?
|
Extracellular Matrix | 1 | 2005 | 1726 | 0.040 |
Why?
|
Social Isolation | 1 | 2000 | 362 | 0.040 |
Why?
|
DNA Adducts | 1 | 1997 | 94 | 0.040 |
Why?
|
Random Allocation | 4 | 1991 | 2394 | 0.030 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1997 | 426 | 0.030 |
Why?
|
Recombination, Genetic | 2 | 1995 | 1526 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 1997 | 2536 | 0.030 |
Why?
|
Hematinics | 1 | 1999 | 281 | 0.030 |
Why?
|
Bone Marrow Transplantation | 3 | 1990 | 2696 | 0.030 |
Why?
|
Isoniazid | 1 | 1978 | 283 | 0.030 |
Why?
|
Extracellular Matrix Proteins | 1 | 2001 | 829 | 0.030 |
Why?
|
Hemoglobins | 3 | 1991 | 1521 | 0.030 |
Why?
|
Muridae | 1 | 1995 | 56 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2012 | 18134 | 0.030 |
Why?
|
Rifampin | 1 | 1978 | 341 | 0.030 |
Why?
|
Mutagenesis | 1 | 2000 | 1234 | 0.030 |
Why?
|
Air Pollutants | 1 | 2010 | 2843 | 0.030 |
Why?
|
Rectal Neoplasms | 1 | 1985 | 1151 | 0.030 |
Why?
|
Middle Aged | 19 | 2012 | 220175 | 0.030 |
Why?
|
Hybrid Cells | 1 | 1995 | 422 | 0.030 |
Why?
|
Environmental Health | 1 | 1998 | 284 | 0.030 |
Why?
|
Pediatrics | 1 | 2011 | 3587 | 0.030 |
Why?
|
Cell Communication | 2 | 2010 | 1642 | 0.030 |
Why?
|
Health Care Costs | 1 | 2009 | 3257 | 0.030 |
Why?
|
Immunoenzyme Techniques | 2 | 2010 | 1705 | 0.030 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 1999 | 538 | 0.030 |
Why?
|
Transforming Growth Factor beta | 2 | 1994 | 1956 | 0.030 |
Why?
|
CD4 Immunoadhesins | 2 | 1991 | 12 | 0.030 |
Why?
|
DNA, Complementary | 2 | 1995 | 1993 | 0.030 |
Why?
|
Drug Tolerance | 2 | 2002 | 369 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2010 | 14396 | 0.030 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 1997 | 412 | 0.030 |
Why?
|
Receptors, Cytokine | 1 | 1995 | 258 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2009 | 3870 | 0.030 |
Why?
|
Species Specificity | 1 | 1999 | 2413 | 0.030 |
Why?
|
Interferon-gamma | 3 | 1990 | 3160 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2004 | 2563 | 0.030 |
Why?
|
Receptors, Colony-Stimulating Factor | 1 | 1994 | 50 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2001 | 1408 | 0.030 |
Why?
|
Paclitaxel | 1 | 2002 | 1738 | 0.030 |
Why?
|
Erythrocyte Transfusion | 1 | 1999 | 566 | 0.030 |
Why?
|
Mice, Inbred C57BL | 4 | 2010 | 22025 | 0.030 |
Why?
|
Crosses, Genetic | 1 | 1995 | 751 | 0.030 |
Why?
|
Pyrimidines | 2 | 2004 | 3011 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 2 | 1995 | 2755 | 0.030 |
Why?
|
Receptors, Retinoic Acid | 1 | 1994 | 224 | 0.030 |
Why?
|
RNA, Messenger | 4 | 2010 | 12762 | 0.030 |
Why?
|
Quality Improvement | 1 | 2009 | 3840 | 0.030 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 1997 | 545 | 0.030 |
Why?
|
Receptors, Very Late Antigen | 1 | 1993 | 74 | 0.030 |
Why?
|
Lymphoma, B-Cell | 1 | 2000 | 935 | 0.030 |
Why?
|
Ganciclovir | 1 | 1994 | 252 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2001 | 1663 | 0.030 |
Why?
|
Erythroid Precursor Cells | 1 | 1994 | 211 | 0.030 |
Why?
|
Collagen | 1 | 2001 | 2635 | 0.030 |
Why?
|
Ceramides | 1 | 1994 | 200 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2006 | 4168 | 0.030 |
Why?
|
Time Factors | 5 | 2005 | 40133 | 0.030 |
Why?
|
Gene Products, gag | 2 | 1990 | 312 | 0.030 |
Why?
|
Colonic Neoplasms | 1 | 1985 | 2526 | 0.030 |
Why?
|
Jurkat Cells | 2 | 2006 | 736 | 0.030 |
Why?
|
Ilium | 1 | 1993 | 154 | 0.030 |
Why?
|
Cytomegalovirus | 1 | 1997 | 756 | 0.030 |
Why?
|
Robotics | 1 | 2000 | 880 | 0.030 |
Why?
|
Mutation | 5 | 2005 | 29950 | 0.030 |
Why?
|
Conserved Sequence | 1 | 1995 | 1168 | 0.030 |
Why?
|
Gene Expression Regulation, Viral | 2 | 1991 | 438 | 0.030 |
Why?
|
Benzo(a)pyrene | 1 | 1991 | 25 | 0.030 |
Why?
|
Ploidies | 1 | 1992 | 275 | 0.020 |
Why?
|
Dependovirus | 1 | 1997 | 708 | 0.020 |
Why?
|
Granulocytes | 1 | 1994 | 551 | 0.020 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 1993 | 377 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2004 | 2532 | 0.020 |
Why?
|
Platelet Count | 2 | 1991 | 777 | 0.020 |
Why?
|
RNA | 2 | 1992 | 2721 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2004 | 3598 | 0.020 |
Why?
|
Thrombocytopenia | 3 | 1989 | 1174 | 0.020 |
Why?
|
Side-Population Cells | 1 | 2010 | 12 | 0.020 |
Why?
|
Polyunsaturated Alkamides | 1 | 2010 | 29 | 0.020 |
Why?
|
Trisomy | 1 | 2012 | 260 | 0.020 |
Why?
|
Organ Specificity | 1 | 1995 | 1955 | 0.020 |
Why?
|
Glycerides | 1 | 2010 | 67 | 0.020 |
Why?
|
Rabbits | 1 | 1997 | 4773 | 0.020 |
Why?
|
Brain | 2 | 1995 | 26912 | 0.020 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2012 | 452 | 0.020 |
Why?
|
Indoles | 2 | 2010 | 1830 | 0.020 |
Why?
|
Hypocalcemia | 1 | 1991 | 199 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2000 | 3483 | 0.020 |
Why?
|
Giant Cells | 1 | 1990 | 185 | 0.020 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 1991 | 285 | 0.020 |
Why?
|
Vinblastine | 2 | 1991 | 487 | 0.020 |
Why?
|
Naphthalenes | 1 | 2010 | 198 | 0.020 |
Why?
|
Amidohydrolases | 1 | 2010 | 163 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 1990 | 866 | 0.020 |
Why?
|
Herpesvirus 4, Human | 2 | 1986 | 1075 | 0.020 |
Why?
|
Adsorption | 1 | 1989 | 197 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2012 | 11341 | 0.020 |
Why?
|
Ionomycin | 1 | 1989 | 109 | 0.020 |
Why?
|
Cell Lineage | 1 | 1998 | 2525 | 0.020 |
Why?
|
Phytohemagglutinins | 1 | 1989 | 168 | 0.020 |
Why?
|
Benzoxazines | 1 | 2010 | 309 | 0.020 |
Why?
|
Ethers | 1 | 1989 | 73 | 0.020 |
Why?
|
Zalcitabine | 1 | 1988 | 43 | 0.020 |
Why?
|
HIV Envelope Protein gp41 | 1 | 1991 | 303 | 0.020 |
Why?
|
Aged | 7 | 2012 | 168995 | 0.020 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1990 | 357 | 0.020 |
Why?
|
Child, Preschool | 2 | 2011 | 42034 | 0.020 |
Why?
|
Tetanus Toxoid | 1 | 1989 | 193 | 0.020 |
Why?
|
Agranulocytosis | 1 | 1988 | 99 | 0.020 |
Why?
|
Neutralization Tests | 2 | 1988 | 729 | 0.020 |
Why?
|
Clone Cells | 1 | 1992 | 1663 | 0.020 |
Why?
|
Solubility | 1 | 1990 | 1088 | 0.020 |
Why?
|
Fetus | 1 | 1995 | 1859 | 0.020 |
Why?
|
Immunoglobulin G | 3 | 1990 | 4546 | 0.020 |
Why?
|
Suramin | 1 | 1987 | 34 | 0.020 |
Why?
|
Pan troglodytes | 1 | 1988 | 224 | 0.020 |
Why?
|
Peripheral Nervous System Diseases | 2 | 1991 | 708 | 0.020 |
Why?
|
Mannose-Binding Lectins | 2 | 1989 | 96 | 0.020 |
Why?
|
Sex Counseling | 1 | 1987 | 17 | 0.020 |
Why?
|
RNA Splicing | 1 | 1992 | 914 | 0.020 |
Why?
|
Depression | 1 | 2007 | 8033 | 0.020 |
Why?
|
Morpholines | 1 | 2010 | 583 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2010 | 633 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2010 | 694 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2007 | 26168 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1991 | 789 | 0.020 |
Why?
|
Stem Cell Niche | 1 | 2010 | 346 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 1990 | 8551 | 0.020 |
Why?
|
Aflatoxins | 1 | 1986 | 12 | 0.020 |
Why?
|
Cartilage | 1 | 1990 | 806 | 0.020 |
Why?
|
Eosinophils | 1 | 1991 | 946 | 0.020 |
Why?
|
Cricetinae | 1 | 1990 | 2427 | 0.020 |
Why?
|
Receptors, Fc | 1 | 1990 | 534 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2001 | 5793 | 0.020 |
Why?
|
Virosomes | 1 | 2005 | 5 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 1997 | 2544 | 0.020 |
Why?
|
Blood Coagulation Disorders | 1 | 1989 | 349 | 0.020 |
Why?
|
Child | 3 | 2011 | 79758 | 0.020 |
Why?
|
Cell Migration Inhibition | 1 | 2005 | 97 | 0.020 |
Why?
|
Health Promotion | 1 | 1998 | 2208 | 0.020 |
Why?
|
Antigens, Differentiation | 1 | 1989 | 912 | 0.020 |
Why?
|
Tumor Necrosis Factors | 1 | 2005 | 106 | 0.020 |
Why?
|
Cyclohexanes | 1 | 2006 | 152 | 0.020 |
Why?
|
Nerve Tissue | 1 | 1985 | 78 | 0.020 |
Why?
|
False Negative Reactions | 1 | 1986 | 574 | 0.020 |
Why?
|
Death Domain Receptor Signaling Adaptor Proteins | 1 | 2005 | 33 | 0.020 |
Why?
|
Vaccines, Synthetic | 1 | 1988 | 617 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 3 | 2002 | 3735 | 0.020 |
Why?
|
DNA Replication | 1 | 1992 | 1412 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2000 | 2557 | 0.020 |
Why?
|
Peptides | 1 | 1997 | 4358 | 0.020 |
Why?
|
Vitronectin | 1 | 2005 | 41 | 0.020 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2005 | 88 | 0.020 |
Why?
|
Head and Neck Neoplasms | 1 | 1999 | 2880 | 0.020 |
Why?
|
Nervous System Diseases | 2 | 1985 | 1647 | 0.020 |
Why?
|
Drug Resistance | 1 | 1991 | 1617 | 0.020 |
Why?
|
Cell Differentiation | 3 | 1992 | 11480 | 0.020 |
Why?
|
Biology | 1 | 1987 | 289 | 0.010 |
Why?
|
Mitochondria, Liver | 1 | 2005 | 190 | 0.010 |
Why?
|
Pancreatitis | 1 | 1991 | 1100 | 0.010 |
Why?
|
Integrin alphaVbeta3 | 1 | 2005 | 105 | 0.010 |
Why?
|
Prognosis | 1 | 2005 | 29636 | 0.010 |
Why?
|
Community Health Centers | 1 | 1988 | 453 | 0.010 |
Why?
|
Endocytosis | 2 | 1990 | 960 | 0.010 |
Why?
|
Adenosine Diphosphate | 2 | 1995 | 429 | 0.010 |
Why?
|
Endonucleases | 1 | 1987 | 370 | 0.010 |
Why?
|
Immunization | 1 | 1988 | 1228 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2001 | 9590 | 0.010 |
Why?
|
Sulfamethoxazole | 1 | 1983 | 54 | 0.010 |
Why?
|
Stress, Physiological | 1 | 2011 | 1395 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 1991 | 2945 | 0.010 |
Why?
|
Down-Regulation | 1 | 1991 | 2918 | 0.010 |
Why?
|
Pulmonary Alveoli | 1 | 1986 | 653 | 0.010 |
Why?
|
Trimethoprim | 1 | 1983 | 85 | 0.010 |
Why?
|
Bacterial Infections | 1 | 1991 | 1402 | 0.010 |
Why?
|
Environmental Exposure | 1 | 1998 | 4404 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2011 | 2138 | 0.010 |
Why?
|
Immunoassay | 1 | 1987 | 748 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2011 | 2202 | 0.010 |
Why?
|
Cerebrospinal Fluid | 1 | 1985 | 544 | 0.010 |
Why?
|
Immunoglobulins | 1 | 1986 | 863 | 0.010 |
Why?
|
Blood Donors | 1 | 1984 | 343 | 0.010 |
Why?
|
Antigens | 1 | 1988 | 1447 | 0.010 |
Why?
|
Needles | 1 | 1985 | 451 | 0.010 |
Why?
|
Cell Death | 1 | 2008 | 1670 | 0.010 |
Why?
|
Jews | 1 | 1984 | 364 | 0.010 |
Why?
|
Blood Coagulation | 1 | 1988 | 1156 | 0.010 |
Why?
|
Phenols | 1 | 2006 | 513 | 0.010 |
Why?
|
Substance-Related Disorders | 3 | 1989 | 4370 | 0.010 |
Why?
|
Africa | 1 | 1984 | 707 | 0.010 |
Why?
|
Carrier State | 1 | 1985 | 525 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1984 | 1628 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 1999 | 15827 | 0.010 |
Why?
|
Membrane Proteins | 1 | 1998 | 7854 | 0.010 |
Why?
|
DNA Helicases | 1 | 1987 | 854 | 0.010 |
Why?
|
Incidence | 1 | 1999 | 21378 | 0.010 |
Why?
|
Tumor Virus Infections | 1 | 1984 | 438 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 1994 | 4554 | 0.010 |
Why?
|
Antibodies | 1 | 1989 | 2424 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 1993 | 39254 | 0.010 |
Why?
|
Receptors, Interleukin-6 | 1 | 2002 | 226 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2010 | 2641 | 0.010 |
Why?
|
Oncogenes | 1 | 1986 | 1221 | 0.010 |
Why?
|
Drug Eruptions | 1 | 1983 | 335 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2002 | 835 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 1999 | 6855 | 0.010 |
Why?
|
Gels | 1 | 2000 | 419 | 0.010 |
Why?
|
Risk | 3 | 1986 | 9629 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 1986 | 1840 | 0.010 |
Why?
|
Molecular Weight | 3 | 1987 | 2186 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 1986 | 2897 | 0.010 |
Why?
|
Blood-Brain Barrier | 1 | 1985 | 1017 | 0.010 |
Why?
|
Growth Inhibitors | 1 | 2000 | 378 | 0.010 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 1982 | 557 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 2002 | 755 | 0.010 |
Why?
|
Health Transition | 1 | 1998 | 35 | 0.010 |
Why?
|
Administration, Cutaneous | 1 | 2000 | 711 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 1989 | 3076 | 0.010 |
Why?
|
Military Personnel | 1 | 1987 | 1245 | 0.010 |
Why?
|
rev Gene Products, Human Immunodeficiency Virus | 1 | 1997 | 27 | 0.010 |
Why?
|
Cytochalasin B | 1 | 1997 | 74 | 0.010 |
Why?
|
Neuregulins | 1 | 1997 | 36 | 0.010 |
Why?
|
Occupational Diseases | 1 | 1985 | 1484 | 0.010 |
Why?
|
Safety | 1 | 2002 | 1149 | 0.010 |
Why?
|
Europe | 1 | 1984 | 3433 | 0.010 |
Why?
|
Survival Rate | 3 | 2002 | 12806 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2002 | 2056 | 0.010 |
Why?
|
Precipitin Tests | 2 | 1989 | 815 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1992 | 14656 | 0.010 |
Why?
|
Dementia | 3 | 1985 | 2638 | 0.010 |
Why?
|
Lymph Nodes | 1 | 1988 | 3491 | 0.010 |
Why?
|
Palatine Tonsil | 1 | 1997 | 193 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 1997 | 575 | 0.010 |
Why?
|
Immunity, Cellular | 2 | 1994 | 1558 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 2002 | 2569 | 0.010 |
Why?
|
Biopsy | 1 | 1987 | 6775 | 0.010 |
Why?
|
Immunohistochemistry | 3 | 1997 | 11064 | 0.010 |
Why?
|
Liver Transplantation | 1 | 1987 | 2317 | 0.010 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 1997 | 750 | 0.010 |
Why?
|
Boston | 1 | 1988 | 9282 | 0.010 |
Why?
|
Thromboxane B2 | 1 | 1994 | 147 | 0.010 |
Why?
|
Double-Blind Method | 4 | 1990 | 12412 | 0.010 |
Why?
|
Receptors, Thrombopoietin | 1 | 1995 | 161 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 1997 | 1433 | 0.010 |
Why?
|
Immunotherapy | 2 | 1994 | 4637 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 1992 | 20048 | 0.010 |
Why?
|
Pneumonia, Pneumocystis | 2 | 1987 | 245 | 0.010 |
Why?
|
Stereoisomerism | 1 | 1994 | 618 | 0.010 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 1995 | 436 | 0.010 |
Why?
|
Genes, Reporter | 1 | 1997 | 1531 | 0.010 |
Why?
|
Prospective Studies | 3 | 1987 | 54263 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1994 | 871 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2010 | 5644 | 0.010 |
Why?
|
Fibrinogen | 1 | 1995 | 887 | 0.010 |
Why?
|
Platelet Aggregation | 1 | 1995 | 805 | 0.010 |
Why?
|
Cell Fusion | 1 | 1992 | 293 | 0.010 |
Why?
|
Lung | 1 | 1990 | 9989 | 0.010 |
Why?
|
TATA Box | 1 | 1991 | 127 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 1987 | 4215 | 0.010 |
Why?
|
DNA Fingerprinting | 1 | 1991 | 111 | 0.010 |
Why?
|
Algorithms | 1 | 2012 | 13967 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1991 | 418 | 0.010 |
Why?
|
Transcription Factor TFIID | 1 | 1991 | 153 | 0.010 |
Why?
|
Biological Availability | 1 | 1991 | 395 | 0.010 |
Why?
|
Feedback | 1 | 1994 | 791 | 0.010 |
Why?
|
Epinephrine | 1 | 1994 | 791 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1994 | 1351 | 0.010 |
Why?
|
Disease Progression | 1 | 2008 | 13505 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 1994 | 729 | 0.010 |
Why?
|
Cytomegalovirus Infections | 1 | 1997 | 831 | 0.010 |
Why?
|
Risk Factors | 2 | 1988 | 74269 | 0.010 |
Why?
|
Primary Prevention | 1 | 1998 | 1207 | 0.010 |
Why?
|
Fluorouracil | 1 | 1995 | 1630 | 0.010 |
Why?
|
Injections, Intramuscular | 1 | 1991 | 553 | 0.010 |
Why?
|
Drug Synergism | 1 | 1994 | 1755 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1994 | 2262 | 0.010 |
Why?
|
Immunity, Maternally-Acquired | 1 | 1990 | 111 | 0.010 |
Why?
|
Serotonin | 1 | 1994 | 1041 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1994 | 2178 | 0.010 |
Why?
|
Pyrazoles | 1 | 2000 | 1992 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1991 | 1388 | 0.010 |
Why?
|
Pregnancy | 2 | 1990 | 29725 | 0.010 |
Why?
|
Cytoplasm | 1 | 1994 | 1518 | 0.010 |
Why?
|
Glycoproteins | 1 | 1997 | 2208 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 1984 | 11141 | 0.010 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 1990 | 303 | 0.010 |
Why?
|
Hematocrit | 1 | 1990 | 630 | 0.000 |
Why?
|
Chromatography, Affinity | 1 | 1989 | 534 | 0.000 |
Why?
|
Immune Sera | 1 | 1988 | 613 | 0.000 |
Why?
|
Inflammation | 1 | 2008 | 10757 | 0.000 |
Why?
|
Bisexuality | 1 | 1989 | 271 | 0.000 |
Why?
|
Genetic Vectors | 1 | 1997 | 3378 | 0.000 |
Why?
|
Erythrocyte Count | 1 | 1987 | 157 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2012 | 58947 | 0.000 |
Why?
|
Chromosome Deletion | 1 | 1991 | 1387 | 0.000 |
Why?
|
Rosette Formation | 1 | 1986 | 152 | 0.000 |
Why?
|
Immunoglobulin A, Secretory | 1 | 1986 | 104 | 0.000 |
Why?
|
Health Policy | 1 | 1998 | 2678 | 0.000 |
Why?
|
Genes, Viral | 1 | 1987 | 650 | 0.000 |
Why?
|
Mutagens | 1 | 1986 | 178 | 0.000 |
Why?
|
Sexual Partners | 1 | 1989 | 750 | 0.000 |
Why?
|
Immunologic Techniques | 1 | 1985 | 213 | 0.000 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 1988 | 618 | 0.000 |
Why?
|
Infusions, Intravenous | 1 | 1990 | 2235 | 0.000 |
Why?
|
Superoxides | 1 | 1986 | 387 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1988 | 2558 | 0.000 |
Why?
|
Integrases | 1 | 1987 | 516 | 0.000 |
Why?
|
Vitamin B 12 | 1 | 1987 | 522 | 0.000 |
Why?
|
Meningitis | 1 | 1985 | 218 | 0.000 |
Why?
|
Spectrometry, Fluorescence | 1 | 1986 | 686 | 0.000 |
Why?
|
Cholesterol Esters | 1 | 1983 | 73 | 0.000 |
Why?
|
Macaca mulatta | 1 | 1990 | 2316 | 0.000 |
Why?
|
Personnel, Hospital | 1 | 1985 | 285 | 0.000 |
Why?
|
Antibody Specificity | 1 | 1985 | 1061 | 0.000 |
Why?
|
Spinal Cord Diseases | 1 | 1985 | 293 | 0.000 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 1990 | 10340 | 0.000 |
Why?
|
Binding Sites | 1 | 1991 | 6050 | 0.000 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1986 | 1549 | 0.000 |
Why?
|
Receptors, LDL | 1 | 1983 | 491 | 0.000 |
Why?
|
Phagocytosis | 1 | 1986 | 1536 | 0.000 |
Why?
|
Syndrome | 1 | 1985 | 3278 | 0.000 |
Why?
|
Adolescent | 1 | 1987 | 87747 | 0.000 |
Why?
|
Transplantation, Homologous | 1 | 1987 | 4814 | 0.000 |
Why?
|
Drug Combinations | 1 | 1983 | 2024 | 0.000 |
Why?
|
Brain Diseases | 1 | 1985 | 1540 | 0.000 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1983 | 1765 | 0.000 |
Why?
|
Ambulatory Care | 1 | 1986 | 2783 | 0.000 |
Why?
|
Acute Disease | 1 | 1985 | 7268 | 0.000 |
Why?
|
Massachusetts | 1 | 1986 | 8805 | 0.000 |
Why?
|
Hospitals | 1 | 1986 | 3929 | 0.000 |
Why?
|
Transcription Factors | 1 | 1991 | 12100 | 0.000 |
Why?
|
Chronic Disease | 1 | 1985 | 9283 | 0.000 |
Why?
|
Rats | 1 | 1986 | 23695 | 0.000 |
Why?
|
Cohort Studies | 1 | 1989 | 41317 | 0.000 |
Why?
|
Hospitalization | 1 | 1986 | 10761 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 1986 | 25928 | 0.000 |
Why?
|
Retrospective Studies | 1 | 1987 | 80301 | 0.000 |
Why?
|